Mitochondrial TDP-43 in Alzheimer's Disease
Mitochondrial TDP-43 in Alzheimer's Disease
批准号:
9815609
负责人:
Xinglong Wang
金额:
$54.89万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-15 至 2020-10-30
关键词:
APP-PS1AddressAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAmyotrophic Lateral SclerosisBehavioralBindingBiochemicalBrainBrain StemCell NucleusCognitionCognitive deficitsComplexCytoplasmDNA Sequence AlterationDementiaDisease ProgressionElderlyEnsureExhibitsExperimental ModelsFrontotemporal DementiaFunctional disorderGeneticGenus HippocampusHippocampus (Brain)ImpairmentInvestigationMeasurementMeasuresMediatingMediator of activation proteinMessenger RNAMitochondriaMolecularMusNADH dehydrogenase (ubiquinone)NeocortexNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronal DysfunctionNeuronsNuclearPathogenesisPathologicPathologyPathway interactionsPatientsPatternPerformancePharmacologyPilot ProjectsPlayPost-Translational Protein ProcessingPreventionProtein BiosynthesisProteinsReportingResolutionRespirationRoleSenile PlaquesSeveritiesSpinal CordSymptomsSynapsesTemporal LobeTestingTissuesToxic effectTransgenic Miceautosomal dominant mutationbasecognitive functionearly onseteffective therapyfrontal lobefrontotemporal lobar dementia-amyotrophic lateral sclerosisimprovedmitochondrial dysfunctionmotor disordermotor neuron degenerationmouse modelneuron lossneuropathologyneurotoxicitynovelnovel therapeutic interventionpreventprotein TDP-43sensorspatiotemporaltau Proteinstreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Alzheimer's disease (AD) is the leading cause of dementia in the elderly, characterized by neurofibrillary
tangles, senile plaques and a progressive loss of neuronal cells in neocortex and hippocampus. Currently,
there is no effective treatment for AD. Genetic mutations in TAR DNA-binding protein 43 (TDP-43) cause
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD, the second most common form of
early-onset dementia), and the increased presence of TDP-43 in the cytoplasm is a prominent
histopathological feature of degenerating neurons in more than half of AD patients. Despite an expanding body
of evidence suggests that TDP-43 may be “the third protein” playing a distinct role in the pathogenesis of AD or
related dementia, in addition to amyloid beta (Aβ) and tau, the molecular pathomechanisms of TDP-43 remain
elusive. Interestingly, in our preliminary studies, we found that TDP-43 became highly associated with
mitochondria in AD patients, neurons treated with Aβ and APP/PS1 (5XFAD) transgenic mice for AD. Based
on identified motifs critical for TDP-43 mitochondrial localization, our most recent study revealed that the
suppression of TDP-43 mitochondrial localization was sufficient to prevent TDP-43-induced neuronal loss, and
improve behavioral performances in TDP-43 transgenic mice, indicating mitochondria as important mediators
for TDP-43 neurotoxicity. Excitingly, the inhibition of TDP-43 mitochondrial localization could significantly
alleviate neuronal death and behavioral deficits in 5XFAD mice well after symptom onset. These exciting and
promising preliminary studies suggest that a detailed investigation into the potential role of mitochondria-
associated TDP-43 in AD and related dementia is warranted. Using both cultured neuronal and transgenic
mouse models for AD and related dementia, this study will test the feasibility of targeting mitochondria-
associated TDP-43 as a novel therapeutic approach for AD and related dementia. The increased presence of
TDP-43 in the cytoplasm is a prominent common histopathological feature of degenerating neurons in various
major neurodegenerative diseases including AD, FTD and ALS. Our proposed studies of mitochondria-
associated TDP-43 and its connection with the generally believed AD culprit Aβ will have very broad scientific
and translational significance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
-
批准号:10766083
-
项目类别:
-
资助金额:$156.83万
-
财政年份:2020
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
-
批准号:10375646
-
项目类别:
-
资助金额:$61.24万
-
财政年份:2020
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial TDP-43 in Alzheimer's Disease
-
批准号:10578054
-
项目类别:
-
资助金额:$115.47万
-
财政年份:2019
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial TDP-43 in Alzheimer's Disease
-
批准号:10766077
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2019
-
负责人:Xinglong Wang
-
依托单位:
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS
-
批准号:10329077
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2017
-
负责人:Xinglong Wang
-
依托单位:
TDP-43 and Mitochondrial Dysfunction in ALS
-
批准号:8799706
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2014
-
负责人:Xinglong Wang
-
依托单位:
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease
-
批准号:8620854
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
Role of PS1 in Mitochondria Dynamics and Mitochondria Function
-
批准号:8490631
-
项目类别:
-
资助金额:$7.91万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease
-
批准号:8729045
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
Role of PS1 in Mitochondria Dynamics and Mitochondria Function
-
批准号:8636966
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2013
-
负责人:Xinglong Wang
-
依托单位:
海外基金